Canadian application, no grantCanada
Tumor proliferation inhibitors
CA 2425264 A1 · Owner: Beaulieu, Francis · Inventors: Beaulieu, Francis; Mahler, Mikael; Ruediger, Edward H.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention concerns novel sugar derivatives of indolocarbazoles and pharmaceutical formulations thereof which exhibit topoisomerase-I activity and are useful in inhibiting the proliferation of tumor cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 28, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 28, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 28, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 28, 2001
GrantedNo grant recorded
Term endedSeptember 28, 2021
Patent numberCA 2425264 A1
Classification (IPC)C07H19/23 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.